NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Eir Ventures

Eir Ventures

Overview

Eir Ventures is a Nordic life science venture fund that invests in companies at early stage, as well as more mature opportunities . The fund seeks investment opportunities addressing significant unmet medical needs for new therapies, medical technology and digital health .

Year Founded

2020

Portfolio Companies

12

Investments

Eir Ventures investments
CompanyDateStageLead
MoleculentApr 2026Series A ExtensionCo-investor
ArgusEye ABApr 2026Early FundingCo-investor
MoleculentJun 2024Series ALead
ArgusEye ABMay 2024SeedCo-investor
Hoba TherapeuticsDec 2023Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSweden
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.